FactorPad
Build a Better Process

Stock Risk Measures for Neogenomics Inc

A quantitative factor review, as of October 30, 2020.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
face pic by Paul Alan Davis, CFA
Updated: November 02, 2020
See how we arrive at an overall risk score of 53 for NEO below.

/ factorpad.com / stocks / f38tgx.html


An ad-free and cookie-free webpage by FactorPad


NEO Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Neogenomics Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how NEO stock compares to 2,000+ US-based stocks, and to peers in the Health Services sector and Medical/Nursing Services industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo NeoGenomics, Inc. is a clinical laboratory company, which specializes in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments. The Clinical Services segment offers cancer testing services to community-based pathologists, hospitals, academic centers, and oncology groups. The Pharma Services segment focuses on supporting pharmaceutical firms in drug development programs by supporting various clinical trials. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.

Identity

Sector and Industry

Share Data

Shares and Float

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f38tgx.html


NEO stock risk
NEOGENOMICS INC stock beta
NEO risk report
NEO f38tgx
NEO risk analysis
NEO volatility
NEOGENOMICS INC credit risk
NEO liquidity risk
NEO leverage
NEO valuation
NEO systematic risk
NEO specific risk
NEOGENOMICS INC volatility
NEO analysis
NEO financial ratio

This is a new resource, spread the word, tell a friend